[New strategy for the treatment of autosomal dominant polycystic kidney disease].
Shigeo
S
Horie
D065092:Antidiuretic Hormone Receptor Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001552:Benzazepines / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D055808:Drug Discovery; D006801:Humans; D058990:Molecular Targeted Therapy; D009154:Mutation; D016891:Polycystic Kidney, Autosomal Dominant / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D017410:Practice Guidelines as Topic; D050396:TRPP Cation Channels; D000077602:Tolvaptan
D065092:Antidiuretic Hormone Receptor Antagonists; D000959:Antihypertensive Agents; D001552:Benzazepines; D050396:TRPP Cation Channels; D000077602:Tolvaptan